Latest Breaking News On - Julianne dorn professor - Page 1 : comparemela.com

Implantable Brain-Computer Interface Collaborative Community (iBCI-CC) to Drive Innovation in Neurotechnology

BOSTON (BUSINESS WIRE) Mar 11, 2024

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved ...

CNM-Au8 30mg treatment demonstrated significantly reduced plasma neurofilament light chain (NfL) levels at 76 weeks relative to placebo (18 months from randomization, p=0.023)60% decreased risk of long-term all-cause mortality (>18

Brain-computer interfaces' safety is similar to other implanted neurologic devices, study shows

For people with paralysis caused by neurologic injury or disease-;such as ALS (also known as Lou Gehrig's disease), stroke, or spinal cord injury-;brain-computer interfaces (BCIs) have the potential to restore communication, mobility, and independence by transmitting information directly from the brain to a computer or other assistive technology.

Low Rate of Adverse Events in Brain Computer Interface Trial